Bankov, K., Döring, C., Ustaszewski, A., Giefing, M., Herling, M., Cencioni, C., . . . Hartmann, S. (2019). Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury. Cancers (Basel).
Citação norma ChicagoBankov, Katrin, et al. "Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined By a Specific Phenotype and Protect Tumor Cells From Brentuximab-Vedotin Induced Injury." Cancers (Basel) 2019.
MLA引文Bankov, Katrin, et al. "Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined By a Specific Phenotype and Protect Tumor Cells From Brentuximab-Vedotin Induced Injury." Cancers (Basel) 2019.
警告：這些引文格式不一定是100％准確.